Biosimilars entering the clinic without animal studies: A paradigm shift in the European Union

Por van Aerts, Leon AGJM, De Smet, Karen, Reichmann, Gabriele, van der Laan, Jan Willem, Schneider, Christian K
Publicado no MAbs (2014)

Nivolumab Enhances In Vitro Effector Functions of PD-1(+) T-Lymphocytes and Leishmania-Infected Human Myeloid Cells in a Host Cell-Dependent Manner

Por Filippis, Christodoulos, Arens, Katharina, Noubissi Nzeteu, Gaetan Aime, Reichmann, Gabriele, Waibler, Zoe, Crauwels, Peter, van Zandbergen, Ger
Publicado no Front Immunol (2017)

Anti-Tumor Necrosis Factor α Therapeutics Differentially Affect Leishmania Infection of Human Macrophages

Por Arens, Katharina, Filippis, Christodoulos, Kleinfelder, Helen, Goetzee, Arthur, Reichmann, Gabriele, Crauwels, Peter, Waibler, Zoe, Bagola, Katrin, van Zandbergen, Ger
Publicado no Front Immunol (2018)